J&J Risperdal Consta Priced Comparable To Zyprexa; Clears FDA Oct. 29

Johnson & Johnson has room to price its long-acting risperidone injection Risperdal Consta 40% higher than Risperdal tablets, while still remaining comparable to Lilly's Zyprexa

More from Archive

More from Pink Sheet